Sumitomo Pharma Co., Ltd. (DNPUF) has a market capitalization of $4.41B and trades at $11.11. The 52-week range is 4-19.2.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.2, Earnings Per Share (EPS) of $59.49, annual revenue of $398.83B.
The stock has a beta of 0.60, operates in the Healthcare sector.
